Therefore, inhibition of cholinesterases [acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE)] and thereby increasing the concentration of ACh in the brain is an attractive target for the treatment of AD.18 Here, ACHE is linked to Alzheimer disease.